No retraction, correction or concern found when last checked on Oct 17, 2026.

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder

Anna Heintz‐Buschart, Urvashi Pandey, Tamara Wicke and 7 more

Movement Disorders · 2017 · CC BY

Abstract

Background. Increasing evidence connects the gut microbiota and the onset and/or phenotype of Parkinson's disease (PD). Differences in the abundances of specific bacterial taxa have been reported in PD patients. It is, however, unknown whether these differences can be observed in individuals at high risk, for example, with idiopathic rapid eye movement sleep behavior disorder, a prodromal condition of α‐synuclein aggregation disorders including PD.

Objectives. To compare microbiota in carefully preserved nasal wash and stool samples of subjects with idiopathic rapid eye movement sleep behavior disorder, manifest PD, and healthy individuals.

Methods. Microbiota of flash‐frozen stool and nasal wash samples from 76 PD patients, 21 idiopathic rapid eye movement sleep behavior disorder patients, and 78 healthy controls were assessed by 16S and 18S ribosomal RNA amplicon sequencing. Seventy variables, related to demographics, clinical parameters including nonmotor symptoms, and sample processing, were analyzed in relation to microbiome variability and controlled differential analyses were performed.

Results. Differentially abundant gut microbes, such as Akkermansia, were observed in PD, but no strong differences in nasal microbiota. Eighty percent of the differential gut microbes in PD versus healthy controls showed similar trends in idiopathic rapid eye movement sleep behavior disorder, for example, Anaerotruncus and several Bacteroides spp., and correlated with nonmotor symptoms. Metagenomic sequencing of select samples enabled the reconstruction of genomes of so far uncharacterized differentially abundant organisms.

Conclusion. Our study reveals differential abundances of gut microbial taxa in PD and its prodrome idiopathic rapid eye movement sleep behavior disorder in comparison to the healthy controls, and highlights the potential of metagenomics to identify and characterize microbial taxa, which are enriched or depleted in PD and/or idiopathic rapid eye movement sleep behavior disorder. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

References 96

1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
3.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
6.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
7.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
8.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
9.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
11.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
12.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
13.
Systematic Design of 18S rRNA Gene Primers for Determining Eukaryotic Diversity in Microbial Consortia · 2014
Corrected
14.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
15.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
16.
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease · 2011
No notice
17.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
18.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
19.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
20.
The RAST Server: Rapid Annotations using Subsystems Technology · 2008
No notice
21.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
22.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
23.
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments · 2010
No notice
24.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
25.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
26.
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data · 2013
No notice
27.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
28.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
29.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
30.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
31.
The nasal microbiota in health and disease: variation within and between subjects · 2015
No notice
32.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
33.
The Non-Protein Amino Acid BMAA Is Misincorporated into Human Proteins in Place of l-Serine Causing Protein Misfolding and Aggregation · 2013
No notice
34.
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease · 2015
No notice
35.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
36.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
37.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
38.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
39.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
40.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
41.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
42.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
43.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
44.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
45.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
46.
Methods for Improving Human Gut Microbiome Data by Reducing Variability through Sample Processing and Storage of Stool · 2015
Corrected
47.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
48.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
49.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
50.
The human gut and groundwater harbor non-photosynthetic bacteria belonging to a new candidate phylum sibling to Cyanobacteria · 2013
No notice
51.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
52.
LotuS: an efficient and user-friendly OTU processing pipeline · 2014
Corrected
53.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
54.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
55.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
56.
The nasal cavity microbiota of healthy adults · 2014
No notice
57.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
58.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
59.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
60.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
61.
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · 2014
No notice
62.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
63.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
64.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
65.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
66.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
67.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
68.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
69.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
70.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
71.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
72.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
73.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
74.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
75.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
76.
Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans · 2016
No notice
77.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
78.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
79.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
80.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
81.
IMP: a pipeline for reproducible reference-independent integrated metagenomic and metatranscriptomic analyses · 2016
No notice
82.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
83.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
84.
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease · 2017
No notice
85.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
86.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
87.
Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function · 2017
No notice
88.
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients · 2017
Corrected
89.
Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life · 2017
No notice
90.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
91.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
92.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
93.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
94.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
95.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
96.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library

Cited by papers we hold 29

Excessive consumption of mucin by over-colonized Akkermansia muciniphila promotes intestinal barrier damage during malignant intestinal environment · 2023
No notice
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies · 2023
No notice
Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives · 2023
No notice
Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management · 2022
No notice
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review · 2022
No notice
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities · 2022
No notice
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease · 2022
No notice
Gut bacterial profiles in Parkinson's disease: A systematic review · 2022
No notice
Periphery and brain, innate and adaptive immunity in Parkinson’s disease · 2021
No notice
Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 13: suitability of taxonomic units notified to EFSA until September 2020 · 2021
Not checked
Role and Mechanism of Gut Microbiota in Human Disease · 2021
No notice
A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson’s disease · 2021
Not checked
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis · 2021
No notice
Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis · 2021
No notice
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation · 2021
No notice
Gut, oral and nasal microbiota and Parkinson’s disease · 2020
Not checked
The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders · 2020
No notice
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens · 2020
No notice
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions · 2020
No notice
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease · 2019
No notice

and 9 more

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.